Carcinoma: all 6,719 studies
Page 61 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell CarcinomaStatus unknownNCT00945984
- Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)CompletedNCT00944905Phase 1
- 4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT00943449Phase 2
- Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal CavityWithdrawnNCT00942838Phase 1
- Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor RiskTerminatedNCT00937612Not applicable
- T-cell Based Immunotherapy for Head and Neck CancerWithdrawnNCT00937300Phase 1
- Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACECompletedNCT00936689Phase 4
- Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer TreatmentStatus unknownNCT00935675Phase 3
- Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell CarcinomaWithdrawnNCT00934518Phase 2
- A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell CarcinomaCompletedNCT00933387Phase 2
- Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell CarcinomaTerminatedNCT00930345Phase 4
- Effectiveness and Safety of Firmagon®CompletedNCT00930319
- Influence of Thyroid Hormones on the Woundhealing ProcessStatus unknownNCT00929318Not applicable
- A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced CancersCompletedNCT00926640Phase 1
- A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaCompletedNCT00924989Phase 3
- Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)CompletedNCT00923897Phase 2
- Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung CancerCompletedNCT00923884
- Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)CompletedNCT00923169Phase 1
- Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma PatientsStatus unknownNCT00922688Not applicable
- A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With Carcinoma of the CervixSuspendedNCT00921635Phase 3
- Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular CarcinomaStatus unknownNCT00921531Phase 3
- Safety Study of Foretinib (GSK1363089) in Adults With Liver CancerCompletedNCT00920192Phase 1
- Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC)CompletedNCT00919009Phase 2
- Human Papillomavirus and Oropharynx CarcinomaStatus unknownNCT00918710
- NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)CompletedNCT00916097Phase 2
- Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)CompletedNCT00914355Phase 2
- Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular CarcinomaCompletedNCT00911196
- Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor InhibitorsCompletedNCT00910676Phase 2
- Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular CarcinomaCompletedNCT00910572Phase 2
- Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCCCompletedNCT00908752Phase 3
- A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer PatientsTerminatedNCT00907166Phase 1/2
- TheraSphere® for Treatment of Unresectable Hepatocellular CarcinomaApproved for marketingNCT00906984
- Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
- Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell CarcinomaTerminatedNCT00903461Phase 1
- A Clinical Study of GP73 as a Hepatocellular Carcinoma (HCC) Tumor MarkStatus unknownNCT00902902
- Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck CancerTerminatedNCT00901537Phase 1
- A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western KenyaCompletedNCT00901173
- YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyTerminatedNCT00899093
- Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck CancerCompletedNCT00899054Phase 1/2
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth CancerTerminatedNCT00896961Not applicable
- Patient Characteristics in Advanced Renal Cell Carcinoma and Daily Practice Treatment With NexavarCompletedNCT00895674
- Impact of Positron Emission Tomography (PET) Imaging in Women With Locally Advanced Cervical Cancer (PET LACE Trial)CompletedNCT00895349Not applicable
- Paclitaxel/Carboplatin With or Without Cetuximab in CUPStatus unknownNCT00894569Phase 2
- Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyCompletedNCT00892736Phase 1
- Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)CompletedNCT00892658Phase 1
- Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma PatientsCompletedNCT00891475Phase 1/2
- Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)CompletedNCT00890903
- Comparison of Set-up Reproducibility Between Prone and Supine Intensity Modulated Radiotherapy (IMRT) for the Adjuvant Treatment of Breast Carcinoma After LumpectomyCompletedNCT00887692Not applicable
- A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsCompletedNCT00886132Phase 2
- An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037CompletedNCT00884520Early Phase 1
- Estimation of Functional Liver Reserve Using CholinesterasesCompletedNCT00883454
- XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00882869Phase 1/2
- Basal Cell Carcinoma Recurrence After Mohs SurgeryCompletedNCT00882791
- Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric CarcinomaStatus unknownNCT00881816Phase 1
- Collection of Tissue Samples for Study of Multidrug ResistanceCompletedNCT00880503
- A Treatment of Unresectable Hepatocellular Carcinoma With TheraSphere®CompletedNCT00877136
- Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell CarcinomaCompletedNCT00876382
- Analysis of Melanocytes (Pigment Cells) in Sun-Exposed SkinCompletedNCT00875381
- Study In Patients With Kidney Cancer Treated With SutentCompletedNCT00873210
- A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck CarcinomaTerminatedNCT00872404Phase 2
- A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular CancerCompletedNCT00872014Phase 2
- Exercise for Patients With Renal Cell Cancer Receiving SunitinibStatus unknownNCT00869011Phase 3
- Measuring Temperatures of Tissues During EndoscopyStatus unknownNCT00868504
- Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the LipCompletedNCT00868088Phase 4
- SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00867750Phase 2
- Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in TaiwanStatus unknownNCT00867633
- Bioequivalence Study of SPARC147609 in Patients With Ovarian CancerCompletedNCT00862355Phase 1
- DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell CarcinomaStatus unknownNCT00862303Phase 1/2
- First Line Hepato Cellular Carcinoma (HCC)CompletedNCT00858871Phase 3
- Analysis of Expression of Specific Markers in Hepatocellular CarcinomaCompletedNCT00858000
- Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial CarcinomaStatus unknownNCT00854464
- Genetic Susceptibility to Kidney CancerTerminatedNCT00854022
- Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma PatientsCompletedNCT00849264Phase 2
- Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma (< 3 cm)on CirrhosisStatus unknownNCT00848952Not applicable
- Study of Sorafenib in Patients With Advanced Renal Cell CarcinomaCompletedNCT00848640Phase 2
- Radiation Dose Escalation Study for Advanced Liver CancerCompletedNCT00848094Phase 1
- Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular CarcinomaCompletedNCT00846131Phase 1
- Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)Status unknownNCT00844688Phase 2
- TK-based Suicide Gene Therapy for Hepatocellular CarcinomaCompletedNCT00844623Phase 1
- Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular CarcinomaCompletedNCT00844454Not applicable
- Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver TransplantCompletedNCT00844168Phase 1
- Trial of Transcatheter Arterial Chemoembolization for Hepatocellular CarcinomaStatus unknownNCT00843934Phase 2/3
- Impact of Predicting Anti-angiogenic Response in mRCC Using Functional ImagingCompletedNCT00842790
- Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular CarcinomaStatus unknownNCT00842647
- The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular CarcinomaWithdrawnNCT00838968Not applicable
- Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular CarcinomaStatus unknownNCT00834860Phase 4
- Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCCCompletedNCT00834158Not applicable
- Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial ChemoembolizationCompletedNCT00834028
- VEGF Imaging in Renal Cell CarcinomaCompletedNCT00831857
- RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)CompletedNCT00830895Phase 2
- A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung CancerTerminatedNCT00830245Phase 2
- Clinical Research of Licartin Combined With TACE in the Treatment of Unresectable Hepatocellular CarcinomaCompletedNCT00829465Phase 4
- Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided ApproachCompletedNCT00829335
- Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00828594Phase 1
- Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With HepatocarcinomaCompletedNCT00827723
- The Role of Low Molecular Weight Heparins in Hepatocellular CarcinomaCompletedNCT00827554Phase 2/3
- Total Hemihepatic Vascular Exclusion in Hepatectomy in Hepatocellular Carcinoma TreatmentCompletedNCT00827047Not applicable
- Transarterial Chemoembolization (TACE) Therapy of Hepatocellular Carcinoma (HCC) With Blocking Tumor Blood Temporarily and Enhancing PerfusionCompletedNCT00826384Phase 1/2
- Treatment of Portal Vein Tumor Thrombus After Hepatocellular Carcinoma ResectionCompletedNCT00825669Not applicable